Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. Considering and approving ....
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Suraksha Diagnostic Ltd has informed exchanges that its Board of Directors will meet on 21 May 2026. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2026. The Board will also take up the recommendation of dividend, if any, on the company's equity shares for the same financial year. The trading window, which was closed from 01 April 2026 for directors, KMPs, designated persons, and employees, will reopen 48 hours after the declaration of the financial results.
This is a routine board meeting intimation for Q4 and full-year FY26 results. Any dividend recommendation could positively impact investor sentiment. The trading window closure ensures compliance with insider trading norms ahead of the price-sensitive financial announcement.